Related Experiment Video
Updated: Sep 21, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
[Hypertrophic cardiomyopathy: from diagnosis to prevention]
R J Hassink1, M J Grosfeld, C Marcelis
1Afd. Cardio-thoracale Chirurgie, Universitair Medisch Centrum, Hart-Long Centrum, Utrecht.
Insights
Genetic screening identified a hypertrophic cardiomyopathy gene mutation in a family. Early DNA testing allows for potential intervention, but further research is needed for effective preventive therapies.
Area of Science:
- Cardiovascular Genetics
- Medical Genetics
Background:
- Familial hypertrophic cardiomyopathy (HCM) is an inherited condition.
- Genetic mutations can predispose individuals to HCM, leading to cardiac arrhythmias and potentially cardiac arrest.
Observation:
- A three-generation family presented with a confirmed gene mutation linked to HCM.
- Affected adult males experienced severe cardiac arrhythmias, requiring medication and defibrillator implantation.
Findings:
- DNA screening can detect HCM-related gene mutations early, even before symptom onset.
- Early diagnosis in asymptomatic carriers presents an opportunity for intervention.
Implications:
- The current lack of robust preventive therapies for genetic HCM creates medical-ethical dilemmas regarding genetic testing.
- Further research into effective preventive strategies is crucial for translating genetic diagnoses into successful disease prevention.
Abstract:
In a 55-year-old man, his two sons aged 32 and 30 years and a 3-year-old grandchild, a gene mutation related to an increased chance of hypertrophic cardiomyopathy was found. The adults had complaints of cardiac arrhythmias varying from dizziness to cardiac arrest and received medication; a defibrillator was also implanted in the case of the sons. Familial hypertrophic cardiomyopathy can be diagnosed in an early stage with DNA screening methods. At that time 'patients' (carriers) often do not exhibit symptoms. This offers the possibility of taking therapeutic measures to prevent or slow down the disease process. However, the scientific basis for preventive therapy is inadequate, so that medical-ethical dilemmas arise which can affect the decision-making process with respect to genetic testing. Additional research must lead to satisfactory preventive therapies, so that in the future the genetic diagnosis 'hypertrophic cardiomyopathy' can be effectively translated into disease prevention.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management

